EGFR-IN-163 (Compound 13) is a competitive epidermal growth factor receptor (EGFR) inhibitor (IC50=0.079 µM, selective for HER-2 inhibition). EGFR-IN-163 induces tumor cell apoptosis and cell cycle arrest at G2/M phase. EGFR-IN-163 is promising for research of estrogen receptor-positive (ER+) breast cancer[1].
Molecular Weight:
679.85
Formula:
C39H49N7O4
Target:
Apoptosis,EGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
